Status quo: Immuntherapie des klarzelligen Nierenzellkarzinoms
Crossref DOI link: https://doi.org/10.1007/s15004-019-6420-5
Published Online: 2019-03-16
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
GrĂ¼llich, Carsten
Text and Data Mining valid from 2019-03-01
Article History
First Online: 16 March 2019